Loading clinical trials...
Loading clinical trials...
Remote Ischemic Preconditioning and Postoperative Neuronal Injury in Non-Cardiac Surgery Patients: A Randomized Trial
The SHIELD trial is a single-center, randomized, controlled, parallel-group, single-blinded clinical trial investigating whether performing RIPC one day before surgery-compared to not performing RIPC-reduces postoperative neuronal injury, as reflected by the maximum serum NfL concentration within the first 2 postoperative days, in non-cardiac surgery patients at risk for postoperative delirium.
Age
50 - No limit years
Sex
ALL
Healthy Volunteers
No
University Medical Center Hamburg-Eppendorf
Hamburg, Hamburg, Germany
Start Date
March 2, 2026
Primary Completion Date
August 1, 2027
Completion Date
September 1, 2027
Last Updated
March 4, 2026
216
ESTIMATED participants
Remote ischemic preconditioning
OTHER
Routine care
OTHER
Bernd Saugel
CONTACT
Lead Sponsor
University of Hamburg-Eppendorf
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions